Top Markets
Coin of the day
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc

APUS
Rank in Stocks #33690
Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage... Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage biopharmaceutical firm operating within the United States. This company is dedicated to the entire lifecycle of its flagship product, Apitox – from its initial investigation and development to its production, market introduction, and sales. Apitox, a key active pharmaceutical ingredient, is specifically designed to alleviate inflammation and manage pain symptoms experienced by individuals suffering from osteoarthritis and multiple sclerosis. Established in 2020, APUS has its corporate headquarters situated in Hopewell, New Jersey, and operates as a subsidiary of Api Meds, Inc.
Share Price
$4.70
Last synced: 2026-08-14
Market Cap
$7.09M
Change (1 day)
-0.21%
Change (1 year)
-70.63%
Country
US
Trade Apimeds Pharmaceuticals US, Inc (APUS)

Category

Stock split history for Apimeds Pharmaceuticals US, Inc (APUS)
Apimeds Pharmaceuticals US, Inc stock (symbol: APUS) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 17, 2026.
One APUS share bought prior to Aug 17, 2026 would equal to 0 APUS shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE